Top Markets
#1 Islamic Coin Islamic Coin +158.25%
#2 Glidr Glidr +58.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#4 Cryptopia Cryptopia +9.96%
#5 Pons Pons +7.79%
#6 Movement Movement +7.49%
#7 Victoria VR Victoria VR +7.22%
#8 龙虾 (Lobster) 龙虾 (Lobster) +6.47%
#9 COTI COTI +5.40%
#10 DMT-NAT DMT-NAT +5.17%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.

EFFECTOR Therapeutics, Inc.

EFTRW
Classement en actions #42260
eFFECTOR Therapeutics, Inc. is a biopharmaceutical firm currently in the... eFFECTOR Therapeutics, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective translation regulator inhibitors aimed at combating cancer. Their primary investigational drug, Tomivosertib, is an orally administered small-molecule MNK inhibitor currently undergoing Phase 2b clinical trials. This candidate is being evaluated for its efficacy in patients suffering from metastatic non-small cell lung cancer. Additionally, the company is advancing zotatifin, another small molecule engineered to block eukaryotic initiation factor 4A (eIF4E). Zotatifin is presently in Phase 1/2 clinical studies for individuals with various solid tumors. Furthermore, it's being tested in a Phase 2a open-label expansion cohort, in conjunction with fulvestrant and abemaciclib, for patients afflicted with ER-positive breast cancer. eFFECTOR Therapeutics, Inc. also holds a research collaboration and licensing pact with Pfizer Inc., focused on co-developing eIF4E inhibitors. Established in 2012, the company maintains its corporate headquarters in Solana Beach, California.
Prix de l'action
$0.0006
Dernière synchronisation: 2025-11-25
Capitalisation boursière
$2.82K
Changement (1 jour)
59,900.00%
Changement (1 an)
59,900.00%
Pays
US
Échange EFFECTOR Therapeutics, Inc. (EFTRW)

Catégorie

Healthcare
Le prix EFTRW avec la capitalisation boursière de B
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.
EFTRW
$0.0006
Capitalisation boursière de EFFECTOR Therapeutics, Inc.(EFTRW)
Capitalisation boursière: $2.82K
En August 2026, EFFECTOR Therapeutics, Inc. a une capitalisation boursière de $2.82K. Cela fait de EFFECTOR Therapeutics, Inc. la 42260th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de EFFECTOR Therapeutics, Inc. du 2021 au 2026
EFTRW par rapport au top 5 des plus populaires stocks
Prix pour EFTRW L’actif B La capitalisation boursière de B Résultats
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.
$1,144,584 $2.82K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +190,763,991,449.54%
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.
$940,480 $2.82K
Apple Inc. Apple Inc.
AAPL
$4.423T +156,746,687,257.60%
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.
$884,558 $2.82K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +147,426,282,463.24%
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.
$778,878 $2.82K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +129,812,937,413.32%
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.
$614,719 $2.82K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +102,453,189,138.36%